Vir Biotechnology (VIR) PT Lowered to $59 at Goldman Sachs
Tweet
Share
E-mailGet Alerts VIR Hot Sheet
Price: $8.04 -1.11%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on Vir Biotechnology (NASDAQ: VIR) to $59.00 (from $61.00) while maintaining a Buy rating.
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Galp Energia (GALP:SM) (GLPEY) PT Raised to EUR20 at Goldman Sachs
- Sanofi (SAN:FP) (SNY) PT Raised to EUR114 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
